Announced Fri, 18 Sept · 20:58 IST
Revised pricing for acquisition of 51 percent stakes in Matrix Labs companies
ONEGLOBAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹542.45
prior close
₹536.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-1.1-0.9+0.7——————————
Up moveDown movePending
AI summary
Board approved revised pricing for acquiring 51 percent stakes in Matrix Labs Diagnocare (Rs 35.98 crore) and Matrix Labs Private Limited (Rs 3.56 crore), totaling about Rs 39.54 crore. Non-cash via 7,06,068 equity shares at Rs 560.13 and Rs 558.99 per share respectively. Revision follows BSE advice on SEBI pricing norms. Move expands presence in diagnostic and healthcare services.
Likely market impact
Existing shareholders face equity dilution from new shares issued as deal consideration, while company adds diagnostic and healthcare businesses.